Oral vitamin C supplementation decreased low-density lipoprotein in adults on hemodialysis: A systematic review and meta-analysis
Nutrition Research · 2025
DOI: 10.1016/j.nutres.2024.09.014 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrition Research, 2025. Verfasst von Issana Marques de Oliveira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Nutrition, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil. Hauptthemen laut MEDLINE: Ascorbic Acid, Dietary Supplements, Lipoproteins, LDL, Renal Dialysis. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Universidade Federal de Santa Catarina.
Abstract (Originalsprache)
Plasma concentration of vitamin C tends to be lower in hemodialysis (HD) patients. Factors that could contribute to this include losses during dialysis and insufficient intake of vitamin C. Furthermore, vitamin C deficiency in HD patients may be related to inflammatory state, oxidative stress, endothelial dysfunction, and cardiovascular disease. We hypothesized that oral vitamin C supplementation improves lipid profile and diminishes inflammation and oxidative stress. Randomized clinical trials (RCTs) and nonrandomized studies (NRS) were analyzed, retrieved from EMBASE, PubMed, Scopus, and Web of Science databases (July 2024). Inclusion criteria: patients (>18 years) on HD; exclusion: intravenous supplementation, animals, children, adolescents, pregnant, lactating, hospitalized, transplanted. The Risk of Bias in Non-randomized Studies of Interventions and Risk of Bias 2 assessed risk of bias. Twelve studies were included (8 RCTs, 4 NRS), involving 549 participants (353 in the vitamin C supplementation, 97 control, 99 placebo). The lipid profile was evaluated in 6. The intervention ranged from 4 to 52 weeks, with doses from 51.4 to 1000 mg/day, orally. Three of 8 RCTs showed high risk of bias and 3 reported some concerns regarding the blinding process. The NRS presented low risk of bias. It was not possible to evaluate inflammation and oxidative stress because of differences in the variables. Meta-analysis showed a reduction in low-density lipoprotein (weighted mean difference: -24.81; I² 79.1%, confidence interval -44.28 to -5.33, P = .008), dose of 107.1-1000 mg/day, for at least 12 weeks. Limitations include the number of studies and patients, and the lack of knowledge about the intake and concentration of vitamin C. Vitamin C supplementation requires further clarification in HD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Nutrition, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
- Department of Pharmacy, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
- Postgraduate Program in Nutrition, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil. Electronic address: e.wazlawik@ufsc.br.
Förderung
- Universidade Federal de Santa Catarina
Zitieren
APA
de Oliveira, I. M., Hauschild, D. B., Machado, R. P., Marques, B. S., & Wazlawik, E. (2025). Oral vitamin C supplementation decreased low-density lipoprotein in adults on hemodialysis: A systematic review and meta-analysis. Nutrition Research. https://doi.org/10.1016/j.nutres.2024.09.014
Vancouver
de Oliveira IM, Hauschild DB, Machado RP, Marques BS, Wazlawik E. Oral vitamin C supplementation decreased low-density lipoprotein in adults on hemodialysis: A systematic review and meta-analysis. Nutrition Research. 2025. doi:10.1016/j.nutres.2024.09.014
BibTeX
@article{deOliveira2025,
author = {de Oliveira, Issana Marques and Hauschild, Daniela Barbieri and Machado, Roberta Pieri and Marques, Bruna Soares and Wazlawik, Elisabeth},
title = {Oral vitamin C supplementation decreased low-density lipoprotein in adults on hemodialysis: A systematic review and meta-analysis},
journal = {Nutrition Research},
year = {2025},
doi = {10.1016/j.nutres.2024.09.014}
}
EUVIMED